BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16469013)

  • 1. Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes.
    Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G
    BJU Int; 2006 Mar; 97(3):485-91. PubMed ID: 16469013
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens.
    Epstein JI; Amin M; Boccon-Gibod L; Egevad L; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
    Scand J Urol Nephrol Suppl; 2005 May; (216):34-63. PubMed ID: 16019758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: the predictors of pelvic lymph node metastasis at radical retropubic prostatectomy.
    Liedberg F
    J Urol; 2004 Oct; 172(4 Pt 1):1545-6. PubMed ID: 15371890
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgical staging of carcinoma of the prostate.
    McCullough DL
    Cancer; 1980 Apr; 45(7 Suppl):1902-5. PubMed ID: 7370940
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of lymphadenectomy for prostate cancer: indications and controversies.
    La Rochelle JC; Amling CL
    Urol Clin North Am; 2011 Nov; 38(4):387-95, v. PubMed ID: 22045170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign glandular inclusion in obturator lymph node of a man treated for prostate carcinoma.
    Moreira Leite KR; Sarkis AS; Camara-Lopes LH
    Pathol Int; 2007 Jul; 57(7):454-7. PubMed ID: 17587246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical prostatectomy for localized prostate cancer.
    Middleton RG
    Semin Urol; 1983 Aug; 1(3):229-35. PubMed ID: 6678471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
    Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
    Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
    Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
    BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histomorphologic studies of prostate biopsies, prostatectomy preparations and lymph node metastases in prostatic cancer].
    Schubert J; Battke H; Hoffmann L; Raatzsch H
    Z Urol Nephrol; 1984 Sep; 77(9):521-8. PubMed ID: 6506894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
    Epstein JI
    Semin Oncol; 1994 Oct; 21(5):527-41. PubMed ID: 7939746
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction with clinically localized prostate cancer before radical prostatectomy].
    Xia WM; Liu DY; Zhou WL; Wang MW; Wang J; Wang Y; Wang SJ; Xu YS; Ye YF; Zhang L
    Zhonghua Wai Ke Za Zhi; 2010 Oct; 48(20):1565-8. PubMed ID: 21176672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.
    Kench JG; Clouston DR; Delprado W; Eade T; Ellis D; Horvath LG; Samaratunga H; Stahl J; Stapleton AM; Egevad L; Srigley JR; Delahunt B
    Pathology; 2011 Aug; 43(5):410-9. PubMed ID: 21716159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case study: management of lymph node-positive disease detected at radical prostatectomy.
    Kirby R
    Prostate Cancer Prostatic Dis; 2005; 8(3):287-9. PubMed ID: 15940288
    [No Abstract]   [Full Text] [Related]  

  • 20. [Locoregional staging of prostatic neoplasms by extemporaneous histological examination of pelvic lymph nodes].
    Zattoni F; Pegoraro V; Guazzieri S; Dal Bianco M
    J Urol (Paris); 1985; 91(3):155-6. PubMed ID: 4045210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.